Method for detecting and laboratory confirmation of inherited chromosomally-integrable human herpes virus 6a/b
RU2743861C1
Crispr-cas system for detecting the antibiotic resistance gene blavim-2 (metallo-beta-lactamase class b vim-2) pseudomonas aeruginosa at ultra-low concentrations
RU2745637C1
Method for obtaining the crispr/cas ribonucleoprotein complex preparation and preparation for detection of the blavim-2 (metal-beta-lactamase class b vim-2) pseudomonas aeruginosa antibiotic resistance gene in ultra-low concentrations
RU2734520C1
Method for detecting the antibiotic resistance gene blavim-2 (metal-beta-lactamase class b vim-2) pseudomonas aeruginosa in ultralow concentrations and specific oligonucleotides for use in the method
RU2720768C1
Crispr-cas system for detecting proviral dna of human immunodeficiency virus integrated into a human genome in ultra-low concentrations
RU2725477C1
Method for detecting the presence of mutations leading to mycoplasma genitalium resistance to macrolide and fluoroquinolone antibiotics
RU2707542C1
METHOD OF PRODUCING A RECOMBINANT NUCLEASE CAS ESSENTIALLY FREE OF BACTERIAL ENDOTOXINS, THE PREPARATION OBTAINED BY THIS METHOD AND CONTAINING A KIT FOR USE IN A CRISPR/Cas SYSTEM
RU2694396C1
RNA-CONDUCTOR St10 FOR USE IN THE HIGHLY SPECIFIC STREPTOCOCCUS THERMOPHILUS CRISPR / Cas9 (StCas9) NUCLEASES SYSTEM AND USE OF SAID RNA-CONDUCTOR AND StCas9 PROTEIN TO SUPPRESS HEPATITIS B VIRUS EXPRESSION IN THE HOST CELL AND FOR VIRAL DNA ELIMINATION FROM THE HOST CELL
RU2652899C1
Rna-conductors to suppress the replication of hepatitis b virus and for the elimination of hepatitis b virus from host cell
RU2655190C1
Method for predicting the severity of diphtheria
RU2666991C1
Genetic constructs and their mixtures for anti-hiv therapy
